Using the NULISAseq CNS disease panel in 1,158 FINGER participants, the analysis found ten plasma proteins, with TREM2 among the strongest, linked to poorer cognitive trajectories regardless of intervention. The multidomain program (diet, exercise, cognitive training, vascular monitoring) shifted eight proteins, including CRH, IL-7 and MME. Eleven proteins modified cognitive response, with KDR and CRH strongest; elastic net models reconfirmed CRH and added PTN and CCL2. APOE ε4- and sex-specific patterns also emerged.

FINGER remains the landmark positive trial of multidomain prevention, yet its mechanisms have been murky; linking lifestyle change to immune, vascular and neuronal protein signals is a credible step toward explaining why it worked. The TREM2 finding fits wider evidence that microglial activation tracks cognitive decline. Caveats matter: this is a preprint awaiting peer review, so results may shift. Proteins were measured at limited timepoints, and effect modification across many proteins invites false positives unless replicated in an independent cohort. The associations are correlational, and responder markers like CRH, a stress-axis peptide, are hypothesis-generating rather than actionable. For readers, nothing here changes advice: the intervention's components remain the evidence-backed message. The precision-prevention promise, identifying who benefits most, is intriguing but years from clinical use. Editorially, this is incremental yet useful mechanistic work building on an established trial.